Client’s Testimonial:
“Thank you so much for your help.”
On March 19th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Pathologist in the Field of Human Pathology (Approval Notice).
General Field: Human Pathology
Position at the Time of Case Filing: Staff Pathologist
Country of Origin: Taiwan
Country of Residence at the Time of Filing: Taiwan
Approval Notice Date: March 19th, 2022
Processing Time: 4 months, 9 days
Case Summary:
A staff pathologist in the field of human pathology, our NIW (National Interest Waiver) client from Taiwan had an M.D. followed by postgraduate training. Her proposed endeavor was to identify genetic mutations that drive cancer development using her expertise in histopathology and molecular diagnostics. She wanted to discover new therapeutic targets and reinvent laboratory workflows that facilitate personalized medicine. It was only evident that her endeavor was of great importance because it had clinical implications for the prognosis and treatment of cancers such as thyroid cancer, other head and neck cancers, and renal cell carcinomas.
It was due to this reason that she could easily obtain 4 letters of recommendation from other experts in her field. Two of these had the following to say:
“Oncologists in the United States report more than 44,000 new cases of thyroid cancer each year. [Client’s] molecular studies of thyroid tumors enable doctors to formulate specialized and effective treatment plans for thousands of affected individuals. By successfully identifying new therapeutic targets and treatment options based on the molecular underpinning of thyroid tumors, [client’s] work streamlines treatment for and improves the survival outlook of Americans with thyroid cancer.”
At the same time, our team gathered additional information to support her claim to the National Interest Waiver category. This meant going through her academic and professional documents. This aided us in finding the following information:
- Our client has completed at least 20 reviews to date.
- Her research has resulted in 20 peer-reviewed journal articles (13 of them first-authored) and 7 published book chapters (all of them first-authored).
- These publications have been cited a total of 273 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of human pathology.
Considering her record of successful research in an area that significantly furthers U.S. interests, our client offers contributions of such value that, on balance, they would benefit the United States even assuming other qualified U.S. workers are available. Thus, while adjudicating, the USCIS favored our client’s case with approval in less than 5 months. We are glad to have her trust and we thank her for continuing to work with us on her EB1-A and I-485 petitions. We wish her all the best in her future endeavors.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.
![](https://www.wegreened.com/blog/wp-content/uploads/2020/03/approval_table_2020.jpg)
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.